Carotuximab - CAS 1268714-50-6

Carotuximab (DE-122) is a novel endocholine antibody with strong antiangiogenic and anti-inflammatory activity. Carotuximab blocks endothelial glycoprotein (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antitumor effects to prevent human endothelial dysfunction induced by hypercholesterolemia and hyperglycemia.

Immunology/Inflammation related, TGF-beta/Smad

Stem Cells, Immunology/Inflammation

1268658

>95%

-20°C

Ice Packs

Inhibitory Antibodies